Lectus Therapeutics Ltd. Acquires NeuroServe

Published: Apr 19, 2006

Bristol, UK, 19 April 2006, Lectus Therapeutics Ltd (“Lectus”), a drug discovery and development company focusing on next-generation ion channel modulators, today announced that it has acquired the assets of NeuroServe Ltd, an electrophysiology company which tests compounds on ion channels for pharmaceutical and biotech clients. The assets purchased by Lectus include intellectual property, equipment and expertise. Lectus has also taken over the lease on the premises located at Babraham in Cambridgeshire, placing the company at the heart of the UK’s leading biotechnology cluster. This acquisition forms an important part of Lectus’s strategy.

Back to news